Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Advances in Cardiovascular Pharmacotherapy. IX. Protection Against Major Adverse Cardiovascular Events by Glucagon-like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus and Obesity
Journal of cardiothoracic and vascular anesthesia, 2026
Advances in Cardiovascular Pharmacotherapy. X. Glucagon-Like Peptide-1 Receptor Agonists in Heart Failure and Mechanisms of Protection
Journal of cardiothoracic and vascular anesthesia, 2026
Therapeutic Benefit or Ocular Risk? Semaglutide and Non-Arteritic Anterior Ischemic Optic Neuropathy: Retraction
Retina (Philadelphia, Pa.);46(8):e95
Semaglutide promotes angiogenesis and blood-brain barrier repair after traumatic brain injury via PDGF-BB/PDGFRβ/Ang1/Tie2/VEGF signaling pathway
Scientific reports, 2026
Evolving utilization of bariatric surgery since the rise of semaglutide and tirzepatide
Surgical endoscopy, 2026
Peripheral artery disease: advances in medical therapy
European heart journal, 2026
Effect of semaglutide on hidradenitis suppurativa disease control and quality of life: A case series
Journal of the European Academy of Dermatology and Venereology : JEADV, 2026
Comparative Cardiovascular Outcomes of Tirzepatide and Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
Journal of the American Heart Association, 2026;:e047018
Trends in Usage and Payments for Glucagon-Like Peptide-1 Receptor Agonists in the United States, 2017 to 2022: A Nationally Representative Repeated Cross-Sectional Study
Journal of the American Heart Association, 2026;:e046302
Glucagon-like peptide-1 receptor agonists in the aging population of people with HIV: emerging evidence and clinical implications
Current opinion in HIV and AIDS, 2026
N-terminally modified GLP1R agonists drive G protein bias via extracellular loop 3 displacement
Cell reports, 2026;45(7):117718
Semaglutide use linked to lower COVID-19 and influenza severity with better renal outcomes after pandemic or seasonal infection
Biology methods & protocols, 2026;11(1):bpag042
Semaglutide for Refractory Reactive Hypoglycaemia: A Case Report
Cureus, 2026;18(7):e112861
Thymosin β4 alleviates sepsis-associated acute kidney injury by suppressing MAPK signaling pathway
Clinical science (London, England : 1979);140(8):1695-1708
[Thymosin β4 inhibits pyroptosis in BV2 microglial cells: a mechanistic study in vitro]
Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics;28(7):877-884
Association of GLP-1 receptor agonists with alcohol use disorder-related and substance use disorder-related hospital admissions during treatment and after discontinuation: a Swedish register-based within-individual observational study
The lancet. Psychiatry;13(8):669-677
Semaglutide vs. liraglutide and incidence of diabetes and cardiovascular disease: A target trial emulation using real-world data
British journal of clinical pharmacology, 2026
Tirzepatide as a therapeutic tool for kidney impairment in obesity: insights from a real-world study
Journal of translational medicine, 2026
Effect of short-term tirzepatide treatment on mean platelet volume in patients with obesity: a retrospective controlled study
BMC endocrine disorders, 2026
The STRIDE Trial and Semaglutide: Implications for Clinical Vascular Practice
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2026